PharmaShots | Incisive News in 3 Shots

Subscribe Now

Chemotherapy-Free Combination

AbbVie Receives US FDA Approval for Imbruvica plus Rituximab for the treatment of Waldenström's macroglobulinemia (WM)

AbbVie Receives US FDA Approval for Imbruvica plus Rituximab for the treatment of Waldenström's macroglobulinemia (WM)

August 28, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us